coronary artery stenosis
Showing 1 - 25 of >10,000
Left Main Coronary Artery Disease Trial (fractional flow reserve (FFR); ultrasonic flow ratio (UFR); intravascular ultrasound
Not yet recruiting
- Left Main Coronary Artery Disease
- fractional flow reserve (FFR); ultrasonic flow ratio (UFR); intravascular ultrasound (IVUS)
- (no location specified)
Sep 22, 2023
Coronary Artery Disease Trial in Seoul (Invasive coronary angiography, Non-invasive functional test)
Not yet recruiting
- Coronary Artery Disease
- Invasive coronary angiography
- Non-invasive functional test
-
Seoul, Korea, Republic ofSamsung Medical Center
Apr 4, 2023
Coronary Artery Disease Trial in Zhenzhou, Wuhan, Taiyuan (Alveo HP Balloon Dilatation Catheter)
Recruiting
- Coronary Artery Disease
- Alveo HP Balloon Dilatation Catheter
-
Zhenzhou, Henan, China
- +2 more
Aug 16, 2023
Ultrasonic Flow Ratio in Assessment of Coronary Artery Lesions
Not yet recruiting
- Coronary Artery Stenosis
- fractional flow reserve (FFR); ultrasonic flow ratio (UFR); intravascular ultrasound (IVUS)
- (no location specified)
Sep 21, 2023
Coronary Artery Stenosis Trial in Shanghai (Non-slip Balloon Catheter of Shanghai MicroPort Rhythm, NSE Coronary Dilatation
Not yet recruiting
- Coronary Artery Stenosis
- Non-slip Balloon Catheter of Shanghai MicroPort Rhythm
- NSE Coronary Dilatation Catheter
-
Shanghai, Shanghai, ChinaRenji Hospital Shanghai Jiaotong University School of Medicine
Nov 7, 2022
Coronary Stenosis Trial in Geneva (Saline Pd/Pa)
Recruiting
- Coronary Stenosis
- Saline Pd/Pa
-
Geneva, SwitzerlandGeneva University Hospitals
Dec 4, 2022
Automated Coronary Magnetic Resonance Angiography for Detection
Not yet recruiting
- Coronary Artery Stenosis
- Coronary Magnetic Resonance Angiography (CMRA)
-
Aarhus, DenmarkAarhus University Hospital
Jul 25, 2022
Safety of RuiXin-CoronaryAI for Diagnosis of Coronary Artery
Recruiting
- Coronary Artery Disease
- +3 more
- RuiXin-CoronaryAI software
-
Beijing, Beijing, China
- +2 more
Sep 19, 2022
Diabetes, Type 2, Major Adverse Cardiac Events Trial in Hangzhou (CGM)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Major Adverse Cardiac Events
- CGM
-
Hangzhou, Chinathe Second Affiliated Hospital Zhejiang University Schoolof Medi
Sep 23, 2023
Coronary Artery Stenosis Trial in Tehran (Anthocyanin-rich diet)
Not yet recruiting
- Coronary Artery Stenosis
- Anthocyanin-rich diet
-
Tehran, Iran, Islamic Republic ofShahid Modares Hospital
Aug 16, 2023
Coronary Artery Stenosis, Coronary Artery Disease, Blood Pressure Trial in Guri, Seoul (percutaneous coronary intervention)
Recruiting
- Coronary Artery Stenosis
- +2 more
- percutaneous coronary intervention
-
Guri, Korea, Republic of
- +2 more
Jun 29, 2023
Coronary Artery Disease, Coronary Artery Stenosis, Coronary Artery Restenosis Trial (behavioral, drug, procedure)
Not yet recruiting
- Coronary Artery Disease
- +6 more
- Healthy life style
- +4 more
- (no location specified)
May 8, 2023
Moderate to Severe Calcified Coronary Artery Stenosis Trial (T-wave coronary lithotripsy catheter system)
Not yet recruiting
- Moderate to Severe Calcified Coronary Artery Stenosis
- T-wave coronary lithotripsy catheter system
- (no location specified)
Dec 21, 2022
Multisensor Array for Localisation of Coronary Artery Stenosis
Not yet recruiting
- CORONARY ARTERY DISEASE
- Application of sensor patch
- (no location specified)
Apr 19, 2022
Disease Characteristics of IR-CAD: a Case-control Study
Not yet recruiting
- Coronary Artery Disease
- +6 more
- Protocol-defined Examinations
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Aug 17, 2023
Prospective Evaluation for Hybrid Cardiac Procedures
Recruiting
- Left Main Coronary Artery Disease
- +7 more
- Coronary artery bypass grafting
- +3 more
-
Roma, ItalyIRCCS Fondazione Policlinico Universitario Agostino Gemelli
Jan 26, 2023
Coronary Artery Stenosis Trial in Seoul (State-of-the-Art Percutaneous Coronary Intervention, standard CABG)
Not yet recruiting
- Coronary Artery Stenosis
- State-of-the-Art Percutaneous Coronary Intervention
- standard CABG
-
Seoul, Korea, Republic ofAsan Medical Center
Apr 14, 2023
Coronary Artery Stenosis, Transcatheter Aortic Valve Implantation Trial in Leipzig (Assession of complete coronary physiology)
Recruiting
- Coronary Artery Stenosis
- Transcatheter Aortic Valve Implantation
- Assession of complete coronary physiology
-
Leipzig, GermanyHeart Center Leipzig at University of Leipzig Department of Inte
Apr 5, 2022
Breast Cancer, Radiation-Induced Vascular Disease, Left Anterior Descending Coronary Artery Stenosis Trial (Respiratory gating)
Not yet recruiting
- Breast Cancer
- +6 more
- Respiratory gating
- (no location specified)
Feb 3, 2023
BIOFLOW-china Post-marketing Study (BIOTRONIK)
Not yet recruiting
- In-Stent Stenosis (Restenosis) of Coronary Artery Stent
- Native Coronary Artery Stenosis
- BIOTRONIK Orsiro Sirolimus-Eluting Coronary Stent System
-
Harbin, Heilongjiang, ChinaThe Fourth Affiliated Hospital of Harbin Medical University
Dec 26, 2022
Coronary Stenosis, Coronary Artery Stenosis, In-stent Restenosis Trial (SINOMED CBC, NSE Coronary Dilatation Catheter)
Not yet recruiting
- Coronary Stenosis
- +2 more
- SINOMED CBC
- NSE Coronary Dilatation Catheter
- (no location specified)
Aug 22, 2022
Coronary Artery Disease Trial in Seoul (Clopidogrel treatment group, No antiplatelet or anticoagulant group)
Recruiting
- Coronary Artery Disease
- Clopidogrel treatment group
- No antiplatelet or anticoagulant group
-
Seoul, Other, Korea, Republic ofSeoul National University Hospital
May 9, 2023
Outcomes After PCI of the Aneurysmatic Right Coronary Artery
Recruiting
- Coronary Disease
- +4 more
- Percutaneous Coronary Intervention
-
Bergamo, Italy
- +7 more
Feb 1, 2023
Coronary Artery Disease, Bypass Graft Stenosis, Dyslipidemias Trial (Computed tomography coronary angiogram)
Not yet recruiting
- Coronary Artery Disease
- +7 more
- Computed tomography coronary angiogram
- (no location specified)
May 24, 2022
Characterize REAL-WORLD EVIDENCE Regarding Safety and
Not yet recruiting
- Coronary Artery Stenosis
- (no location specified)
Sep 7, 2022